FDA Inspection 1073617 — Incyte Corporation
The FDA completed an inspection of Incyte Corporation on November 28, 2018 in Wilmington, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 28, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Wilmington, DE (United States)
Additional Details
Sponsor, Contract Research Organization